Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial. uri icon

authors

  • Ji, Niannian
  • Gelfond, Jon
  • Maiti, Sourindra
  • Cooper, Laurence J N
  • Svatek, Robert S
  • Mukherjee, Neelam
  • Morales, Edwin E
  • Tomasini, Maggie E
  • Hurez, Vincent
  • Curiel, Tyler J
  • Abate, Getahun
  • Hoft, Dan F
  • Zhao, Xiang-Ru

publication date

  • May 25, 2019